{"url_path":"/sec/idya/8-k/2026-06-23/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/1676725/0001193125-26-279427-index.html","accession_number":"0001193125-26-279427","cik":"0001676725","ticker":"IDYA","issuer_name":"IDEAYA Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1676725/0001193125-26-279427-index.html","primary_entity_key":"0001676725","primary_entity_name":"IDEAYA Biosciences, Inc."},"word_count":281,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 16, 2026, IDEAYA Biosciences, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 29, 2026. Only stockholders of record as of the close of business on April 20, 2026, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 87,860,920 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:\n\nProposal 1. The election of three Class I directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are elected:\n\n \n\nNominee\n\n  \nVotes For\n \n  \nVotes Withheld\n \n  \nBroker\nNon-Votes\n \n\nYujiro S. Hata\n\n  \n \n70,546,418\n \n  \n \n2,470,077\n \n  \n \n10,089,343\n \n\nM. Garret Hampton, Ph.D.\n\n  \n \n56,718,637\n \n  \n \n16,297,858\n \n  \n \n10,089,343\n \n\nCatherine J. Mackey, Ph.D.\n\n  \n \n70,281,521\n \n  \n \n2,734,974\n \n  \n \n10,089,343\n \n\nProposal 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026:\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n82,579,758\n \n141,240\n \n384,840\n\nAs a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.\n\nProposal 3. The non-binding, advisory vote to approve the compensation of the Company’s named executive officers:\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n \n\nBroker Non-Votes\n\n64,269,756\n \n8,349,131\n \n397,608\n \n10,089,343"}